Peptides you’ll hear about
Status as of October 2026. Rules are changing, so check the date on each article and the current rule on the FDA’s website.
| Peptide | Status | What to know |
|---|---|---|
| Bremelanotide (Vyleesi) | FDA-approved | Approved for low sexual desire in premenopausal women. Sold online as “PT-141.” |
| Melanotan II | Research-only | A tanning peptide linked in case reports to mole changes and nausea. |
| Kisspeptin | Research-only | Being studied for reproductive hormones. Kisspeptin-10 is on an FDA safety-risk list for compounding. |